Abstract
Post-discharge death is increasingly recognized as an important contributor to pediatric mortality in sub-Saharan Africa. To address morbidity and mortality during this period, a representative evidence base is needed to inform resource prioritization, policy, and guideline development. To date, no studies have been conducted in Rwanda, limiting understanding of post-discharge mortality in this region. We conducted a prospective cohort study of children ages 0-60 months in two Rwandan hospitals, one rural (Ruhengeri) and one urban (Kigali), from May 2022 to February 2023. We collected clinical, laboratory, and sociodemographic data on admission and follow-up data on vital statistics at 2-, 4-, and 6-months post-discharge. Of 1218 children enrolled, 115 (9.4%) died, with half occurring in-hospital (n=57, 4.7%) and half after discharge (n=58, 4.7%). Post-discharge mortality was lower in the 6-60-month cohort (n=30, 3.5%) than in the 0-6-month cohort (10%) and higher in Kigali (n=37, 10.3%) vs. Ruhengeri (n=21, 2.7%). Median time to post-discharge death was 38 days (IQR: 16-97.5) in the 0–6-month cohort and 33 days (IQR: 12-76) in the 6– 60-month cohort. In the 0-6 months cohort, malnutrition (weight-for-age z-score <-3) was associated with increased odds of post-discharge death (aOR 3.31, 95% CI 1.28-8.04), while higher maternal education was protective (aOR 0.15, 95% CI 0.03-0.85). Significant factors associated with post-discharge death in the 6-60-month cohort included an abnormal Blantyre Coma Scale (aOR 3.28, 95% CI 1.47-7.34), travel time to care >1 hour (aOR 3.54, 95% CI 1.26-9.93), and referral for higher levels of care (aOR 4.13, 95% CI 1.05-16.27). Children aged <2 months exhibited the highest cumulative mortality risk. Post-discharge mortality among Rwandan children remains a significant burden, necessitating targeted interventions for post-discharge care and follow up to reduce mortality.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Protocols
https://borealisdata.ca/dataset.xhtml?persistentId=doi:10.5683/SP3/NTNTZX
Funding Statement
This study was funded by an Early Career Award from the Thrasher Foundation (Hooft), the University of British Columbia, and the UCSF Department of Emergency Medicine Global Health Section
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethics Committees of the University of California, University of British Columbia, University Teaching Hospital of Kigali, and University of Kigali all gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced are available online through the Smart Discharges Dataverse in deidentified format.
https://borealisdata.ca/dataset.xhtml?persistentId=doi:10.5683/SP3/60DTRF
